Citigroup
GWPH

Citigroup’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Citigroup’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42,600
Closed -$4.92M – 7827
2020
Q4 		$4.92M Buy
42,600
+4,500
+12% +$504K ﹤0.01% 2105
2020
Q3 		$3.71M Sell
38,100
-3,600
-9% -$414K ﹤0.01% 2120
2020
Q2 		$5.12M Sell
41,700
-29,500
-41% -$3.35M ﹤0.01% 1841
2020
Q1 		$6.24M Buy
71,200
+13,500
+23% +$1.43M 0.01% 1494
2019
Q4 		$6.03M Buy
57,700
+12,700
+28% +$1.42M ﹤0.01% 1878
2019
Q3 		$5.18M Sell
45,000
-15,600
-26% -$2.37M ﹤0.01% 1903
2019
Q2 		$10.4M Buy
60,600
+4,200
+7% +$726K 0.01% 1363
2019
Q1 		$9.51M Buy
56,400
+9,600
+21% +$1.43M 0.01% 1299
2018
Q4 		$4.56M Buy
46,800
+14,600
+45% +$1.92M ﹤0.01% 1892
2018
Q3 		$5.56M Buy
32,200
+2,900
+10% +$418K 0.01% 1756
2018
Q2 		$4.09M Buy
29,300
+13,700
+88% +$1.95M ﹤0.01% 2020
2018
Q1 		$1.76M Sell
15,600
-10,400
-40% -$1.31M ﹤0.01% 2718
2017
Q4 		$3.43M Sell
26,000
-2,100
-7% -$247K ﹤0.01% 2183
2017
Q3 		$2.85M Buy
28,100
+12,300
+78% +$1.32M ﹤0.01% 2287
2017
Q2 		$1.58M Sell
15,800
-47,000
-75% -$5.06M ﹤0.01% 2824
2017
Q1 		$7.59M Buy
62,800
+11,400
+22% +$1.4M 0.01% 1334
2016
Q4 		$5.74M Sell
51,400
-2,000
-4% -$241K 0.01% 1678
2016
Q3 		$7.09M Sell
53,400
-31,900
-37% -$3.05M 0.01% 1351
2016
Q2 		$7.81M Buy
85,300
+38,500
+82% +$3.24M 0.01% 1213
2016
Q1 		$3.38M Buy
46,800
+11,300
+32% +$620K ﹤0.01% 1926
2015
Q4 		$2.46M Buy
35,500
+9,100
+34% +$741K ﹤0.01% 2322
2015
Q3 		$2.41M Buy
26,400
+1,000
+4% +$111K ﹤0.01% 2278
2015
Q2 		$3.12M Buy
25,400
+7,500
+42% +$851K ﹤0.01% 2156
2015
Q1 		$1.63M Buy
+17,900
New +$1.45M ﹤0.01% 2640

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Citigroup's GWPH Position: Q2 2021 in Review

Citigroup sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 73,319 shares — an estimated $15.9M sold.

Citigroup first reported a position in GWPH in Q4 2013 and held it in 30 quarters. The position peaked at $15.9M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Citigroup reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Citigroup sold 73,319 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $15.9M.
  • Citigroup first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 30 quarters.
  • Citigroup's GW Pharmaceuticals Plc American Depositary Shares position peaked at $15.9M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.